LGVN - Financial Reports List - Longeveron Inc. - IntrinsicAlpha

Longeveron Inc. LGVN

Healthcare - Biotechnology - NASDAQ - US

$ 1.475

3.4 %

$ 22.1 M

Market Cap

-0.58

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	857.14%	32.30%	21.31%
Annual Report	FY	10-K	2024-12-31	237.38%	25.41%	21.43%
Quarterly Report	Q3	8-K	2024-09-30	415.33%	25.15%	9.92%
Quarterly Report	Q2	8-K	2024-06-30	115.67%	39.40%	38.73%
Quarterly Report	Q1	8-K	2024-03-31	96.42%	11.36%	13.27%
Quarterly Report	Q4	8-K	2023-12-31	-47.93%	-59.81%	-3.84%
Annual Report	FY	10-K	2023-12-31	-41.98%	-9.10%	-16.55%
Quarterly Report	Q3	8-K	2023-09-30	-43.40%	-11.38%	0.50%
Quarterly Report	Q2	8-K	2023-06-30	-53.43%	19.85%	-35.32%
Quarterly Report	Q1	8-K	2023-03-31	-24.59%	-26.25%	-38.95%

1